1
ALL1
Boehringer Ingelheim GmbHYear
1
ALL1
2022DEALS // DEV.
1
ALL1
DevelopmentsCountry
1
ALL1
GERMANY1
ALL1
Not ApplicableTherapeutic Area
1
ALL1
Pulmonary/Respiratory DiseasesStudy Phase
1
ALL1
ApprovedDeal Type
0
ALLProduct Type
1
ALL1
Small moleculeDosage Form
1
ALL1
SprayLead Product
1
ALL1
Tiotropium BromideTarget
0
ALLLead Product(s) : Tiotropium Bromide,Olodaterol Hydrochloride
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : STIOLTO RESPIMAT (tiotropium bromide and olodaterol) Inhalation Spray is a prescription medicine used long term, 2 puffs 1 time each day, in controlling symptoms in adults with chronic obstructive pulmonary disease (COPD).
Brand Name : Stiolto Respimat
Molecule Type : Small molecule
Upfront Cash : Not Applicable
November 17, 2022
Lead Product(s) : Tiotropium Bromide,Olodaterol Hydrochloride
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?